Reneuron Share Discussion Threads

[dickbush] 29/11/2016 15:39

Interims due out on Monday, the same day as the result of the Italian Referendum. If, as expected, the result is a NO to Mr Renzi, the market may provide a poor background. On the other hand, when have the polls got it right recently?

[stewart_25] 29/11/2016 09:55

Right now i would settle for 11p - just over break even!

[rayrac] 28/11/2016 12:11

No need to over-cook it chrisdgb! 👉🏿😜🤑

[chrisdgb] 28/11/2016 11:29

I see Stifel have an 11p price target..................!!

[dibs61] 26/11/2016 11:58

adorling - agreed. Things about to become interesting as test results will drop with interims

[adorling] 25/11/2016 18:06

We have broken the downtrend and can now look forward to our Interims on 5th Dec. I expect us to have surpassed 3p before next Friday close.

[stewart_25] 25/11/2016 11:32

just need another 50 of them lol

[chrisdgb] 25/11/2016 11:22

Looks like a decent size buy got us going upwards today..............

[macmoss] 22/11/2016 13:40

Investment trusts and Unit trusts do not pay capital gains on their profits that occur within the fund, neither can losses benefit them. Capital gains or losses are only realised when private investors sell their investments in the fund. Provided the gains made by the private investor are within the annual capital gains allowance then no tax is due. So it would be of no tax benefit to Neil Woodford to sell from one fund and buy in another.

[rayrac] 22/11/2016 12:41

Do bio's ever take off? I've been 'in' this heap for so long, paint drying has nothing on this dog!

👉🏿💤😱9411;

[fredd1eboy] 21/11/2016 16:56

Thanks Alpha. I understand your reasoning in that the sell would be detrimental to the fund share holders and therefore unacceptable. So back to reasoning why have so many shares been sold so cheaply so close to news. Doesn't seem logical, even given the low volumes. What about shares being bought cheaply by Rene with the aid of their big investors for eventual distribution as Director/SM bonus payments?
At least acquiring them at sub 3p impacts less than acquiring at 6p + on news. Here's hoping.
Thoughts!

[alphapig] 21/11/2016 16:17

Freddie, as I see it (layman), the funds are two separate vehicles with different individual investors in each. To do as you suspect, it would point towards dodgy practises/accounting. Just my opinion.He would have to sell from one fund in open market, for the benefit of investors in that one fund, and buy in open market for the other fund and investors. Just doesn't sit right with me somehow, but like I say, just a layman.

[chrisdgb] 21/11/2016 11:53

Let us hope we can build nicely into the results...

[fredd1eboy] 21/11/2016 11:18

A question for the more experienced than I .....

Neil Woodford has two funds each containing Reneuron shares.
The original one is an main stream managed equity investment fund which has been running for longer than the newest fund which is a Trust fund.
Am I correct in assuming that there is a much lower potential capital gains liability for the latter aim held funds?
My reason for asking is that although Neil cannot exceed his 35% ish holding in Reneuron can his fund benefit from selling Reneuron from one fund into the other. If so, currently could he not claim a capital loss on the original fund as the share price is so low and then enjoy a tax efficient capital gain for the Trust fund when Rene shares come of age.
My only reason for questioning is that this strategy would place some logic on whats been going on for so many months.
Informed views appreciated

[fredd1eboy] 17/11/2016 18:11

I'm hoping for a break through 3.5p during next week and back to 5p plus before 5th. Lets face it, it would place the share price back where it was 14 months ago. Since then the company has blossomed. Watch this space. Best wishes. Freddie

[adorling] 17/11/2016 17:53

Let's hope 5th Dec is our early Xmas present and we see impressive progress in the trial update and our price move through 3.5p resistance.

[fredd1eboy] 14/11/2016 07:25

ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, intends to announce its interim results for the six months ended 30 September 2016 on Monday 5 December 2016.

The Company also expects to announce initial three month follow-up data from the PISCES II clinical trial of its CTX cell therapy candidate for stroke disability on the same day.

A meeting for analysts will be held at 9.00am on the morning of 5 December 2016 at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.

For a webcast of the analyst presentation, please log on to the following web address approximately 10 minutes before 9.00am on the day of the results:

hxxp://vm.buchanan.uk.com/2016/reneuron051216/registration.htm


A recording of the presentation will be made available on ReNeuron's and Buchanan's websites, www.reneuron.com and www.buchanan.uk.com

[dogwalker] 09/11/2016 09:59

Wasn't Mrs Clinton supposed to be a threat to biotech cos.? If so I'd imagine a bit of a bounce for the sector at some point ( not necessarily today!). And that in turn could encourage the situation a bit over here, inc maybe even this company's valuation.

[fredd1eboy] 09/11/2016 09:14

Im thankful for there being no issue of news before today. Looks like Rene got it spot on. Although I am not a fan, best hold tight and see where the trump card leads us. Good luck all Freddie

[fredd1eboy] 08/11/2016 12:00

We need some seriously good news to take the share price northwards to hold firm. The delivery is key and hopefully in stages. A whambam thank you man aint going to work. Just hope our pr has learnt from past episodes.not long to wait now.
best of luck all. Freddie

[john henry] 08/11/2016 10:52

8 years and still plodding along between 2-3p

[dogwalker] 04/11/2016 10:22

Good thinking, waterloo01 !

[waterloo01] 04/11/2016 08:46

Added a few this AM. Getting close to some important results. Hopefully patients continue to see positive progression.